Topics in this section

Hepatitis and HIV: latest news

Hepatitis and HIV resources

  • Other tests

    Blood pressure is the force that the beating heart causes in the arteries, veins, and blood vessels that carry blood around the body. Blood pressure is measured...

    From: Booklets

    Information level Level 2
  • How hepatitis C is passed on during sex

    Hepatitis C can be passed on during sex that could lead to contact with semen, rectal mucus or blood.Many gay men with HIV have picked...

    From: The basics

    Information level Level 1
  • The liver

    The liver plays an important role in how the body processes anti-HIV drugs.Hepatitis means inflammation of the liver and is relatively common in people with...

    From: Factsheets

    Information level Level 2
  • Hepatitis and other liver disease

    The liver has many important functions in the body. For people with HIV, it plays a vital role in processing the drugs used to treat HIV. Some...

    From: Booklets

    Information level Level 2
  • Hepatitis B

    The majority of people with hepatitis B do not have any symptoms.It is recommended that people living with HIV are tested and vaccinated for hepatitis...

    From: Factsheets

    Information level Level 2
  • Hepatitis C

    A blood test for antibodies will show if you have been exposed to hepatitis C.HIV treatment has particular benefits for people with HIV and hepatitis...

    From: Factsheets

    Information level Level 2
  • Liver function tests

    People living with HIV should have regular blood tests to monitor liver function.The liver plays an important role in processing drugs used to treat HIV...

    From: Factsheets

    Information level Level 2
  • Managing advanced liver disease

    Over years or decades, chronic hepatitis B or C can cause serious liver disease including advanced fibrosis, cirrhosis or liver cancer (hepatocellular cancer). As scar tissue or tumours...

    From: Booklets

    Information level Level 2
  • Hepatitis C treatment for people with co-infection

    Current guidelines recommend that you start hepatitis C treatment if you have HIV and HCV co-infection with moderate or worse liver fibrosis (stage F2 to F4) and...

    From: Booklets

    Information level Level 2
  • HIV & hepatitis

    This booklet gives information for people with HIV who also have hepatitis A, hepatitis B or hepatitis C....

    From: Booklets

    Information level Level 2
  • HIV and hepatitis co-infection

    Hepatitis is a viral infection that affects your liver. Some types – hepatitis B and C – can cause long-term, serious health problems. Many people with HIV...

    From: Booklets

    Information level Level 2
  • Hepatitis C

    Hepatitis C is a serious infection caused by a virus.It damages the liver, which performs essential functions in the body.Some people have hepatitis C for...

    From: The basics

    Information level Level 1
  • Hepatitis C treatment

    Deciding on the best time to take treatment for hepatitis C is not straightforward.It’s important to get support and advice to help you with this...

    From: The basics

    Information level Level 1
  • How hepatitis C is passed on

    When the blood of a person who has hepatitis C enters the bloodstream of another person, that person could get hepatitis C.Tiny and unseen traces...

    From: The basics

    Information level Level 1

Hepatitis and HIV features

Hepatitis and HIV in your own words

Hepatitis and HIV news from aidsmap

More news

Hepatitis and HIV news selected from other sources

  • WHO prequalifies first generic hepatitis C medicine and first HIV self-test

    WHO today prequalified the first generic version of sofosbuvir, a critical medicine for the treatment of hepatitis C. The development could expand access to treatment by increasing the number of quality-assured generic medicines on the market. Sofosbuvir, 400 mg tablet, is manufactured by Mylan Laboratories Ltd., India.

    22 July 2017 | World Health Organization
  • Targeting MSM with HIV: Treatment as Prevention in the Netherlands

    As part of Dutch HIV guidelines, all individuals with HIV are screened for hepatitis C. Anne Boerekamps, MD, of Erasmus University Medical Center in Rotterdam, the Netherlands, spoke with HCV Next about the Dutch approach, the relevant data, and other topics associated with screening and treating MSM.

    18 July 2017 | Healio Hepatology
  • US: New Hepatitis C Infections Nearly Tripled over Five Years

    Over just five years, the number of new hepatitis C virus infections reported to CDC has nearly tripled, reaching a 15-year high, according to new preliminary surveillance data released today by the Centers for Disease Control and Prevention (CDC).

    12 May 2017 | CDC
  • New report halves the number of people infected with hepatitis C worldwide

    A new World Health Organization (WHO) report chops the estimated number of people around the world living with the liver-damaging hepatitis C virus (HCV) in half—but the drop has nothing to do with the recent advent of powerful drugs that cure the disease for most everyone. The dramatic drop occurred primarily because of tests that measured HCV’s genetic material, RNA, in people. Previous epidemiological surveys tested whether people had antibodies against the virus, which is less precise.

    02 May 2017 | Science
  • New Canadian guideline: No screening for hepatitis C in adults not at increased risk

    The Canadian Task Force on Preventive Health Care recommends against screening for chronic hepatitis C virus in adults at low risk in a guideline published in Canadian Medical Association Journal.

    25 April 2017 | Eurekalert Inf Dis
  • Optimism About HCV Treatment Comes With Caveats

    Despite significant advances in treatment for individuals with HCV infection, several important issues prevail in this patient population.

    22 March 2017 | Medscape
  • WHO guidelines on hepatitis B and C testing

    These are the first WHO guidelines on testing for chronic HBV and HCV infection and complement published guidance by WHO on the prevention, care and treatment of chronic hepatitis C and hepatitis B infection. These guidelines outline the public health approach to strengthening and expanding current testing practices for HBV and HCV, and are intended for use across age groups and populations.

    21 February 2017 | World Health Organization
  • European Commission Grants Marketing Authorization for Gilead’s Vemlidy® (Tenofovir Alafenamide, TAF) for the Treatment of Chronic Hepatitis B Virus Infection

    Vemlidy® is the First New Treatment for Chronic Hepatitis B Infection to be Approved in the European Union in Nearly a Decade

    12 January 2017 | Gilead press release
  • Hepatitis C Sheds Enough in the Rectum to Transmit Through Anal Sex

    Researchers have come up with the first direct evidence that enough hepatitis C virus (HCV) sheds into the rectums of HIV-positive men who have sex with men (MSM) to transmit directly to another man’s penis during anal sex, even when no blood is present.

    30 November 2016 | Poz
  • DAA treatment restricted for Canadian hepatitis C patients

    Patients infected by hepatitis C virus (HCV) in Canada have limited access to direct-acting antiviral (DAA) agents, according to a new study. For example, 85% to 92% of the provinces and territories in Canada restrict access to these medications to persons with moderate fibrosis.

    29 November 2016 | Medical Economics
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.

See also

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.